[
  {
    "ts": null,
    "headline": "3 Stocks Trading At Discounts Of Up To 48.8% Below Estimated Intrinsic Value",
    "summary": "As the U.S. stock market navigates through a period of volatility with mixed earnings reports and geopolitical tensions, investors are keenly observing opportunities amid fluctuating indices. In such an environment, identifying stocks trading below their intrinsic value can offer potential for long-term growth, making them attractive considerations for those looking to capitalize on market inefficiencies.",
    "url": "https://finnhub.io/api/news?id=d357608c8b5ee629f4e1fe4d89b9b2fcd2fa5b5c57fe3d10faf806360e3ffbb6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760636282,
      "headline": "3 Stocks Trading At Discounts Of Up To 48.8% Below Estimated Intrinsic Value",
      "id": 137121772,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "As the U.S. stock market navigates through a period of volatility with mixed earnings reports and geopolitical tensions, investors are keenly observing opportunities amid fluctuating indices. In such an environment, identifying stocks trading below their intrinsic value can offer potential for long-term growth, making them attractive considerations for those looking to capitalize on market inefficiencies.",
      "url": "https://finnhub.io/api/news?id=d357608c8b5ee629f4e1fe4d89b9b2fcd2fa5b5c57fe3d10faf806360e3ffbb6"
    }
  },
  {
    "ts": null,
    "headline": "Calico Appoints Philip R. Kym, Ph.D., as Head of Drug Discovery",
    "summary": "Calico Life Sciences LLC (Calico), a biotechnology organization focused on aging and age-related diseases and founded by Alphabet Inc. and Arthur D. Levinson, Ph.D., today announced the appointment of Philip R. Kym, Ph.D., as its Head of Drug Discovery. In this newly created role, Dr. Kym will oversee the direction, scientific execution, and operational management of Calico's drug discovery programs, from target identification and validation through lead optimization and candidate selection.",
    "url": "https://finnhub.io/api/news?id=5e91ffd56eb8dee8c62626bfbf6545f94109b499c566285676c3f4ab496e6cb3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760616000,
      "headline": "Calico Appoints Philip R. Kym, Ph.D., as Head of Drug Discovery",
      "id": 137104369,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Calico Life Sciences LLC (Calico), a biotechnology organization focused on aging and age-related diseases and founded by Alphabet Inc. and Arthur D. Levinson, Ph.D., today announced the appointment of Philip R. Kym, Ph.D., as its Head of Drug Discovery. In this newly created role, Dr. Kym will oversee the direction, scientific execution, and operational management of Calico's drug discovery programs, from target identification and validation through lead optimization and candidate selection.",
      "url": "https://finnhub.io/api/news?id=5e91ffd56eb8dee8c62626bfbf6545f94109b499c566285676c3f4ab496e6cb3"
    }
  },
  {
    "ts": null,
    "headline": "October 2025 Value Picks: 3 Stocks That May Offer Attractive Valuations",
    "summary": "As the U.S. stock market navigates through a period of volatility, highlighted by impressive bank earnings and ongoing trade tensions with China, investors are keenly observing economic indicators for signs of stability. In this environment, identifying stocks that may be undervalued could offer potential opportunities for those looking to capitalize on attractive valuations amidst fluctuating market conditions.",
    "url": "https://finnhub.io/api/news?id=c433fd1bb4db0f453a62d28d2d5431b5e0e69f0744621d69d323a543534517fa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760614679,
      "headline": "October 2025 Value Picks: 3 Stocks That May Offer Attractive Valuations",
      "id": 137104455,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "As the U.S. stock market navigates through a period of volatility, highlighted by impressive bank earnings and ongoing trade tensions with China, investors are keenly observing economic indicators for signs of stability. In this environment, identifying stocks that may be undervalued could offer potential opportunities for those looking to capitalize on attractive valuations amidst fluctuating market conditions.",
      "url": "https://finnhub.io/api/news?id=c433fd1bb4db0f453a62d28d2d5431b5e0e69f0744621d69d323a543534517fa"
    }
  },
  {
    "ts": null,
    "headline": "Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.",
    "summary": "Investors should be able to count on these stocks to deliver steady and growing income over the long term.",
    "url": "https://finnhub.io/api/news?id=7e4800b5ba3d8b3036f1e4db47b26b94b80d7f16abe3b07b08340919642c68aa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760611500,
      "headline": "Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.",
      "id": 137104447,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Investors should be able to count on these stocks to deliver steady and growing income over the long term.",
      "url": "https://finnhub.io/api/news?id=7e4800b5ba3d8b3036f1e4db47b26b94b80d7f16abe3b07b08340919642c68aa"
    }
  },
  {
    "ts": null,
    "headline": "Cantor Fitzgerald Reaffirms Overweight Rating on AbbVie (ABBV)",
    "summary": "AbbVie Inc. (NYSE:ABBV) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now. A global pharmaceutical company, AbbVie Inc. (NYSE:ABBV) is among the best dividend stocks in the healthcare sector. On October 14, C‍antor Fitzgerald reaffirmed⁠ its Overwe⁠ight rating a⁠nd $2‍5⁠0 price targ⁠et‌ f‍or AbbVie Inc. (NYSE:ABBV) while revising its earnings model⁠ to […]",
    "url": "https://finnhub.io/api/news?id=14326cbdaca1990da736d5f0b398d6e4ccf7fe58fb3d1b5aa253004645424851",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760593747,
      "headline": "Cantor Fitzgerald Reaffirms Overweight Rating on AbbVie (ABBV)",
      "id": 137101944,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie Inc. (NYSE:ABBV) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now. A global pharmaceutical company, AbbVie Inc. (NYSE:ABBV) is among the best dividend stocks in the healthcare sector. On October 14, C‍antor Fitzgerald reaffirmed⁠ its Overwe⁠ight rating a⁠nd $2‍5⁠0 price targ⁠et‌ f‍or AbbVie Inc. (NYSE:ABBV) while revising its earnings model⁠ to […]",
      "url": "https://finnhub.io/api/news?id=14326cbdaca1990da736d5f0b398d6e4ccf7fe58fb3d1b5aa253004645424851"
    }
  }
]